In a Drug Safety Communication released in July 2020, the Food and Drug Administration (FDA) recommends health-care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medications to treat opioid use disorder. According to the FDA, health-care professionals should discuss the availability of naloxone, and consider prescribing it to patients who are at increased risk of opioid overdose. Information on naloxone and information specifically for health-care professionals can be found on the FDA’s website. Also be sure to visit APMA's Opioid Use and Abuse Prevention Page.
Intended for homologous use in the treatment acute and chronic wounds, EpiFix allografts may be stored at ambient conditions for up to 5 years and are available in a variety of sizes. Explore the use of EpiFix® in your wound treatment applications.
Recognizing the symptoms of burnout is the first step toward better self-care.
Editor's note: visit www.apma.org/wellbeing for many resources to help you cope with burnout. See APMA's infographic on the symptoms of physician burnout.
The DERMACLOSE Continuous External Tissue Expander device facilitates rapid tissue movement to reduce or reapproximate wounds. After the initial application has been completed the DERMACLOSE device does not require any additional tightening. Once the desired tissue expansion has occurred the device(s) can be removed and the wound can be closed with suture or staples.
Based on a number of factors, including salary and the cost of malpractice premiums, Mississippi topped the list of physician-friendly states, followed by Alaska and Idaho.
